
    
      A Randomized, Open Label, Active Controlled (Mometasone Furoate Aqueous Nasal Spray
      [NasonexÂ®] 200mcg QD), Parallel Group, Multi-Center, 52-Week Study to Assess the Long Term
      Safety of GW685698X Aqueous Nasal Spray 100mcg QD via Nasal Biopsy in Subjects >18 Years of
      Age with Perennial Allergic Rhinitis (PAR)
    
  